These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28448888)

  • 1. Isolation, identification and characterization of potential impurities of anidulafungin.
    Zhao L; Wang Q; Bie Y; Lu X
    J Pharm Biomed Anal; 2017 Jul; 141():192-199. PubMed ID: 28448888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, identification, and characterization of potential impurities of doramectin and evaluation of their insecticidal activity.
    Zhang Q; Cheng Y; Yang J; Zheng C; Lu X
    J Pharm Biomed Anal; 2020 Nov; 191():113600. PubMed ID: 32977199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
    Kumar N; Devineni SR; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, identification and characterization of two novel process-related impurities in olanzapine.
    Zhuang T; Zhang W; Cao L; He K; Wang Y; Li J; Chen L; Liu B; Zhang G
    J Pharm Biomed Anal; 2018 Apr; 152():188-196. PubMed ID: 29414012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan.
    Feng WD; Zhuo SM; Zhang FL
    J Pharm Biomed Anal; 2019 Feb; 165():325-337. PubMed ID: 30579233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
    Yan F; Liu J; Zeng X; Zhang Y; Hang T
    Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, separation and characterization of process-related impurities of bifendate derivative (DB-6), an investigational agent combating acute liver failure.
    Ye W; Yang Y; Wang G; Luo Y; Chen L
    J Chromatogr Sci; 2015; 53(5):716-24. PubMed ID: 25238768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR.
    Kumar N; Devineni SR; Gajjala PR; Dubey SK; Kumar P
    J Pharm Anal; 2017 Dec; 7(6):394-400. PubMed ID: 29404065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR.
    Wang J; Zhou J; Xu Y; Zhu B; Jin Y
    J Pharm Biomed Anal; 2020 May; 184():113196. PubMed ID: 32113121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, Characterization, and Quantification of Impurities of Safinamide Mesilate: Process-Related Impurities and Degradation Products.
    Zou L; Sun L; Zhang H; Hui W; Zou Q; Zhu Z
    J AOAC Int; 2017 Jul; 100(4):1029-1037. PubMed ID: 28150570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structural characterization of eight impurities in aztreonam.
    Li Y; Yuan M; Ding D; Jiang X; Ye Q; Guo F
    J Pharm Biomed Anal; 2022 Feb; 210():114587. PubMed ID: 35026590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC analysis, semi-preparative HPLC preparation and identification of three impurities in salidroside bulk drug.
    Peng Y; Luo J; Lu Q; Chen X; Xie Y; Chen L; Yang W; Du S
    J Pharm Biomed Anal; 2009 Apr; 49(3):828-32. PubMed ID: 19167183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities - part I.
    Dubrovay Z; Háda V; Béni Z; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():293-308. PubMed ID: 22985529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, synthesis and structural characterization of process related and degradation impurities of acrivastine and validation of HPLC method.
    Kumar A; Devineni SR; Dubey SK; Kumar P; Srivastava V; Ambulgekar G; Jain M; Gupta DK; Singh G; Kumar R; Hiriyanna SG; Kumar P
    J Pharm Biomed Anal; 2017 Jan; 133():15-26. PubMed ID: 27969063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of novel process-related impurities in empagliflozin.
    Chen Y; Li H; Hong H; Tao H; Peng X; Xu G
    J Pharm Biomed Anal; 2021 May; 198():114001. PubMed ID: 33735784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of unknown degradation impurities in beclomethasone dipropionate cream formulation using HPLC, ESI-MS and NMR.
    Sambandan E; Kathavarayan T; Sellappan S; Shiea J; Ponnusamy VK
    J Pharm Biomed Anal; 2019 Apr; 167():123-131. PubMed ID: 30771645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.